63 related articles for article (PubMed ID: 26890683)
21. Implementation of a human papillomavirus screen-and-treat model in Mwanza, Tanzania: training local healthcare workers for sustainable impact.
Bernstein M; Hari A; Aggarwal S; Lee D; Farfel A; Patel P; Raman K; Raja S; Fenning R; Lieber M; Minteer W; Denny S; Ries M
Int Health; 2018 May; 10(3):197-201. PubMed ID: 29579207
[TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy of cryotherapy combined with interferon in the treatment of chronic cervicitis complicated with HPV infection.
Su Y; Zhang M; Zhang W; Shi H
Pak J Pharm Sci; 2017 Jul; 30(4(Suppl.)):1505-1508. PubMed ID: 29044006
[TBL] [Abstract][Full Text] [Related]
23. Effects of Maintenance on Quality of Performance of Cryotherapy Devices for Treatment of Precancerous Cervical Lesions.
Maza M; Figueroa R; Laskow B; Juárez A; Alfaro K; Alonzo TA; Felix JC; Gage JC; Cremer M
J Low Genit Tract Dis; 2018 Jan; 22(1):47-51. PubMed ID: 29271857
[TBL] [Abstract][Full Text] [Related]
24. Comments on the article, “Primary ADN-VPH screening in women under 30 years of age: health technology assessment”.
Campos-Ponce HF; Castro-Mamani S; Ocaña-Fernández Y
Rev Colomb Obstet Ginecol; 2023 Mar; 74(1):90-91. PubMed ID: 37093938
[No Abstract] [Full Text] [Related]
25. Reply to: “Comments on the article entitled “Primary ADN-VPH screening in women under 30 years of age: health technology assessment”.
Garzón-Olivares CD; Grillo-Ardila CF; Amaya-Guío J
Rev Colomb Obstet Ginecol; 2023 Mar; 74(1):92-94. PubMed ID: 37093934
[No Abstract] [Full Text] [Related]
26. Cervical cancer screening coverage in the Americas region: a synthetic analysis.
Fernández-Deaza G; Serrano B; Roura E; Castillo JS; Caicedo-Martínez M; Bruni L; Murillo R
Lancet Reg Health Am; 2024 Feb; 30():100689. PubMed ID: 38332935
[TBL] [Abstract][Full Text] [Related]
27. Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future.
Alfaro K; Soler M; Maza M; Flores M; López L; Rauda JC; Chacón A; Erazo P; Villatoro N; Mumenthaler E; Masch R; Conzuelo G; Felix JC; Cremer M
Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681756
[TBL] [Abstract][Full Text] [Related]
28. Outcomes for Step-Wise Implementation of a Human Papillomavirus Testing-Based Cervical Screen-and-Treat Program in El Salvador.
Alfaro K; Maza M; Felix JC; Gage JC; Castle PE; Alonzo TA; Chacón A; González E; Soler M; Conzuelo-Rodriguez G; Masch R; Cremer M
JCO Glob Oncol; 2020 Oct; 6():1519-1530. PubMed ID: 33064628
[TBL] [Abstract][Full Text] [Related]
29. The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador.
Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Masch R; Cremer M; Kim JJ
Int J Gynaecol Obstet; 2019 Apr; 145(1):40-46. PubMed ID: 30702142
[TBL] [Abstract][Full Text] [Related]
30. Advancing Reliable Data for Cancer Control in the Central America Four Region.
Piñeros M; Frech S; Frazier L; Laversanne M; Barnoya J; Garrido C; Gharzouzi E; Chacón A; Fuentes Alabi S; Ruiz de Campos L; Figueroa J; Dominguez R; Rojas O; Pereira R; Rivera C; Morgan DR
J Glob Oncol; 2018 Sep; 4():1-11. PubMed ID: 30241165
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country.
Maza M; Alfaro K; Garai J; Velado MM; Gage JC; Castle PE; Felix J; Luciani S; Campos N; Kim J; Masch R; Cremer M
Gynecol Oncol Rep; 2017 May; 20():58-61. PubMed ID: 28337474
[TBL] [Abstract][Full Text] [Related]
32. Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador.
Cremer ML; Maza M; Alfaro KM; Kim JJ; Ditzian LR; Villalta S; Alonzo TA; Felix JC; Castle PE; Gage JC
J Low Genit Tract Dis; 2016 Apr; 20(2):145-50. PubMed ID: 26890683
[TBL] [Abstract][Full Text] [Related]
33. Scale-Up of an Human Papillomavirus Testing Implementation Program in El Salvador.
Cremer M; Maza M; Alfaro K; Morales Velado M; Felix J; Castle PE; Kim J; Gage JC
J Low Genit Tract Dis; 2017 Jan; 21(1):26-32. PubMed ID: 27922905
[TBL] [Abstract][Full Text] [Related]
34. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador.
Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Cremer ML; Kim JJ
Int J Cancer; 2015 Aug; 137(4):893-902. PubMed ID: 25639903
[TBL] [Abstract][Full Text] [Related]
35. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
36. The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador.
Campos NG; Alfaro K; Maza M; Sy S; Melendez M; Masch R; Soler M; Conzuelo-Rodriguez G; Gage JC; Alonzo TA; Castle PE; Felix JC; Cremer M; Kim JJ
Prev Med; 2020 Feb; 131():105931. PubMed ID: 31765712
[TBL] [Abstract][Full Text] [Related]
37. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
